Aster Hospital Mankhool and Medcare Hospital Al Safa Recognized for Medical Excellence at the Dubai Quality Group Award
Aster Hospital Mankhool and Medcare Hospital Al Safa, part of Aster DM Healthcare—the leading integrated healthcare provider in the GCC—have been recognized for their commitment to quality and innovation in healthcare at the prestigious Dubai Quality Group Award held recently. The two hospitals achieved top honors, with Aster Hospital Mankhool securing the Gold category and Medcare Hospital Al Safa earning the Silver category at the 1st Cycle of the Medical Excellence MENA Award, organized by the Medical Excellence Subgroup of Dubai Quality Group.
Under the patronage of His Highness Sheikh Ahmed bin Saeed Al Maktoum, the Medical Excellence Subgroup of Dubai Quality Group launched this esteemed award to promote a culture of excellence, innovation, and safety in the healthcare sector across the UAE, GCC, and MENA region. The award recognizes institutions that set benchmarks in quality healthcare delivery, aligning with globally accepted best practices and fostering patient-centric care.
The award ceremony, held at the Habtoor Ballroom, Al Habtoor Palace, was attended by His Highness Sheikh Ahmed bin Saeed Al Maktoum, Chairman of Dubai Civil Aviation Authority, Chairman of Dubai Airports and Chairman and Chief Executive of Emirates Airline and Group, along with Dr. Hazza Khalfan Alnuaimi, Chairman of Dubai Quality Group. The event, hosted by Mrs. Sameera Mohammed, General Manager of Dubai Quality Group, brought together over 600 dignitaries, state and regional leaders, executive presidents, and representatives from local and international media, celebrating outstanding contributions to healthcare excellence.
Speaking on this remarkable achievement, Dr. Malathi Arshanapalai, Group Chief Medical Officer and Group Chief Quality Officer, Aster DM Healthcare, said, 'This accolade reinforces our mission to set new benchmarks in clinical excellence, safety, and patient experience across our hospitals. At Aster, there has been a paradigm shift in the way we measure clinical excellence – moving from a provider perspective to the receiver's perspective. In simple terms, we capture our clinical outcomes as determined by the patients' reporting outcomes of care (PROM – Patient Reported Outcome Measures) and patients' reporting their experience of care (PREM – Patient Reported Experience Measures). This ensures great value add to the patients, which was well appreciated during the assessment.'
Dr. Arshanapalai added, 'Aster Hospital Mankhool's recognition in the Gold category and Medcare Al Safa's Silver category win are a testament to the dedication of our teams in delivering high-quality, patient-centric care. These achievements highlight our unwavering commitment to adopting best practices, ensuring optimal healthcare outcomes, and continuously innovating to meet the evolving needs of our patients.'
Echoing this sentiment, Dr. Sherbaz Bichu, CEO of Aster Hospitals and Clinics, UAE, Oman & Bahrain, emphasized the significance of this recognition, stating, 'Receiving the Dubai Quality Group Award is a testament to Aster's unwavering commitment to delivering world-class healthcare services. Aster Hospital Mankhool's recognition in the Gold category reflects our dedication to clinical excellence, patient safety, and continuous innovation. Our highly skilled professionals and the clinical expertise of our doctors have won us this recognition, topped with rigorous protocols ensuring the best possible clinical outcomes. Above all, compassion and empathy are our core values, and today we stand proud of this accolade. This honor fuels our passion to elevate healthcare standards and enhance patient experiences across the region.'
Adding to the celebration, Dr. Shanila Laiju, Group CEO of Medcare Hospitals and Medical Centres, stated, 'Medcare Hospital Al Safa's Silver category win highlights our commitment to medical excellence and a patient-first approach. We will continue to implement advanced medical practices and innovations that enhance patient care and strengthen the UAE's position as a global healthcare hub.'
The Medical Excellence MENA Award under Dubai Quality Group was established to promote the UAE as a health tourism hub, foster a competitive healthcare environment, ensure safe and high-quality medical care, and integrate ESG (Environmental, Social, and Governance) principles into healthcare institutions. The award aligns with the UAE's vision of elevating healthcare standards and promoting sustainable excellence in the industry.
In addition to these accolades, Aster DM Healthcare has recently been honored with the Dubai Quality Appreciation Award, reinforcing its position as a leading healthcare provider committed to excellence. Aster Hospital Mankhool has also achieved accreditation from the Emirates International Accreditation Centre, further validating its commitment to maintaining the highest standards in patient safety and healthcare delivery. Medcare Hospital Al Safa continues to raise the bar with its Joint Commission International (JCI) reaccreditation, emphasizing its adherence to global best practices in healthcare.
The recognition of Aster Hospital Mankhool and Medcare Hospital Al Safa at the Dubai Quality Group Award further solidifies their position as leaders in delivering exceptional healthcare services. Their dedication to medical excellence, patient safety, and quality care continues to set new benchmarks for the region's healthcare landscape, reinforcing their commitment to innovation and world-class healthcare delivery.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mid East Info
06-05-2025
- Mid East Info
DHA explores new healthcare partnership with India's KIMS Group - Middle East Business News and Information
DUBAI, United Arab Emirates, May , 2025: His Excellency Awadh Seghayer Al Ketbi, Director General of the Dubai Health Authority (DHA), met on Monday with a delegation from KIMS Hospitals Group, which is based in Hyderabad, India. The delegation was led by Dr Rakesh Jalla, Senior Vice President for International Business and Partnerships, and the meeting focused on exploring opportunities for collaboration in specialised healthcare, diagnostics, medical education, and scientific research. The two sides discussed potential cooperation in training programmes, improving patient experience, sharing expertise, and facilitating professional exchange between medical personnel in the UAE and India. They also examined the possibility of patient referrals from the UAE to KIMS hospitals in India, aiming to enhance healthcare integration and expand access to specialised treatment options. The meeting, attended by several DHA executives, also addressed plans to bolster diagnostic capabilities in Dubai through the establishment of KIMS Group's first international diagnostic centre in the UAE. The centre will provide advanced, specialised diagnostic services in line with global standards. The meeting comes as UAE–India relations continue to strengthen, particularly following the recent official visit of His Highness Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, Crown Prince of Dubai, Deputy Prime Minister and Minister of Defence of the UAE, and Chairman of The Executive Council of Dubai, to India. The visit opened new avenues for cooperation across a range of vital sectors, including healthcare. During the meeting, HE Awadh Seghayer Al Ketbi reaffirmed the Dubai Health Authority's commitment to expanding international partnerships and attracting world-class medical expertise. He noted that this aligns with the vision of His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, to place human health at the forefront of government planning. It also supports directives from HH Sheikh Hamdan bin Mohammed to strengthen Dubai's preparedness and global leadership in the healthcare sector. Al Ketbi highlighted the Authority's interest in forging a strategic partnership with KIMS Hospitals Group, one of South Asia's leading healthcare institutions with long-standing expertise in specialised care. He added that the DHA continues to foster a favourable investment environment, supported by advanced infrastructure and flexible regulations, enhancing Dubai's competitiveness as a regional healthcare and investment hub. He stressed that such partnerships serve as key drivers for the goals of the 'Dubai Economic Agenda D33,' and support wider government efforts to cultivate a business environment conducive to growth. He also underlined the vital role of the private sector as a strategic partner in advancing Dubai's healthcare ecosystem. The KIMS Hospitals delegation commended Dubai for offering flexible and collaborative partnership opportunities, reflecting the emirate's clear vision to empower global medical institutions in advancing healthcare delivery. The delegation expressed pride in partnering with the Dubai Health Authority and operating in a city that leads the region in healthcare progress. During the meeting, the delegation outlined the group's services and achievements, which include operating 16 specialised hospitals with a combined capacity of over 5,000 beds, serving more than 600,000 patients annually. The hospitals cover more than 25 medical specialties, including organ transplantation, cardiology, oncology, neurosciences, robotic surgery, and other advanced disciplines. The group also highlighted the capabilities of its flagship hospital in Hyderabad, which houses 1,000 beds and holds five quality accreditations — making it the most accredited hospital of its kind, the largest private hospital in South India, and one of the most distinguished in the country for quality, specialisation, and innovation. The KIMS delegation expressed their aspiration to build a long-term partnership with the Dubai Health Authority to support improved patient experiences, enhance quality of life, and reinforce Dubai's position as a regional hub for advanced healthcare.
Mid East Info
24-04-2025
- Mid East Info
Dubai Health Authority Director General: We Are Leveraging AI to Transform Healthcare
His Excellency Awadh Seghayer Al Ketbi, Director General of the Dubai Health Authority (DHA), reaffirmed Dubai's strong commitment to adopting advanced technologies, highlighting artificial intelligence (AI) as a key driver of global competitiveness and progress in healthcare. Speaking at the AI in Healthcare Forum , held during Dubai AI Week under the theme 'Enhancing Healthcare with AI' , Al Ketbi noted that AI today represents one of the world's most critical challenges and opportunities. He added that Dubai recognised the strategic importance of AI early on, thanks to the visionary leadership of His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, and the guidance of His Highness Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, Crown Prince of Dubai, Deputy Prime Minister & Minister of Defence of the UAE, and Chairman of the Board of Trustees of Dubai Future Foundation (DFF).. 'This forum comes at a time when AI is reshaping societies and transforming the future of healthcare,' said Al Ketbi. 'At DHA, we are working tirelessly to integrate AI and the latest technologies into our healthcare systems and policies, with a focus on improving service quality and patient outcomes.' Al Ketbi also emphasised DHA's commitment to building strategic partnerships with leading local and global institutions to enrich its capabilities and accelerate progress in the field of AI. The AI in Healthcare Forum brought together leading global experts and decision-makers to explore how artificial intelligence can enhance healthcare delivery, streamline operations, and support data-driven decision-making. Key topics discussed included: AI's vision for healthcare by 2031 The ongoing AI revolution in healthcare Patient data privacy in the age of innovation Real-world applications and challenges of AI in healthcare Next-generation emergency response powered by AI A high-level panel: From Strategy to Execution – Making AI Work in Healthcare The forum welcomed an impressive lineup of global thought leaders and innovators, including: Dr. Anton Dahbura, Executive Director, Johns Hopkins University Information Security Institute, Co-Director, Johns Hopkins Institute for Assured Autonomy Deven Pandey, Vice President at Gartner Prof. Akin Osman, Faculty Member, MINES Paris – PSL and Caltech; Director, Data Innovation Lab, IHEIE Lina Shahid, Health Industries Leader at PWC Rany Al Baghdadi, Chief Revenue & Strategy Officer, Keyzana John Roster, Strategy Director, RUVOS Kari Bhimaya, Chief Technology & Innovation Officer, Capgemini The forum underscored Dubai's role as a global hub for healthcare innovation and its ongoing efforts to drive forward a smarter, more efficient healthcare future powered by artificial intelligence.
Mid East Info
15-04-2025
- Mid East Info
Aster Hospital Mankhool Introduces Cutting-Edge Robotic Orthopedic Centre - Middle East Business News and Information
Aster Hospital Mankhool, ranked No. 4 on Newsweek's World's Best Hospitals in the UAE list for 2025, has launched its state-of-the-art Robotic Surgery Centre, marking a significant advancement in orthopedic care with the introduction of the ROSA® Robotic Knee Joint Replacement System. This cutting-edge robotic surgical assistant works alongside surgeons from pre-surgery planning through to the procedure itself, enhancing accuracy and reducing the risk of surgical errors in bone preparation and implant placement. As the first robotic surgery facility within Aster Hospitals in the UAE, this milestone underscores the hospital's commitment to providing world-class, technology-driven healthcare solutions. The Robotic Surgery Centre was officially inaugurated by Olympic boxing legend and former Rajya Sabha Member, Mary Kom, who lauded the hospital's commitment to innovation and patient-centric advancements in healthcare. Studies indicate that the global knee replacement market is projected to reach USD 17.35 billion by 20341, driven by an increasing aging population, osteoarthritis and rising patient demand for effective, long-lasting treatments. Robotic-assisted knee replacement surgery addresses the challenges of traditional procedures by offering greater precision, reducing recovery time, and improving implant longevity. ROSA® assists surgeons by generating a 3D model of the patient's knee using preoperative CT scans (rather than X-rays), enabling a highly personalized and accurate surgical approach. By providing real-time data and intraoperative feedback, the system ensures optimal implant positioning, reduces surgical errors, and enhances joint function. The robotic assistance allows for customized treatment plans tailored to each patient's unique anatomy, significantly improving overall results. Commenting on the launch, Dr. Malathi Arshanapalai, Group Chief Medical Officer and Group Chief Quality Officer, Aster DM Healthcare, said 'At Aster, we are committed to continuously innovating and adopting advanced technologies that improve patient outcomes. The introduction of the robotic knee joint replacement system at Aster Hospital Mankhool is a testament to our vision of making high-quality, technology-driven healthcare accessible to our patients. With robotic-assisted surgery, we are bringing the future of orthopedic care to the region, ensuring more precision, faster recovery, and better overall experiences for patients undergoing knee replacement procedures.' The adoption of robotic-assisted knee replacement surgery at Aster Hospital Mankhool includes both knee and hip replacement surgeries, bringing multiple advantages over traditional procedures. Patients benefit from smaller incisions, minimal tissue disruption, and a reduced risk of complications, such as infections and nerve damage. The advanced technology enhances joint stability, ensuring proper alignment and lowering the risk of misalignment-related issues. Moreover, the precision of robotic assistance leads to improved implant longevity, potentially extending the lifespan of the prosthetic knee. Dr. Ranjith Narayan, Specialist Orthopaedics, Aster Hospital Mankhool, added, 'The introduction of the ROSA® Robotic Knee Joint Replacement System at Aster Hospital Mankhool is a game-changer in orthopedic care. This advanced robotic system enhances surgical precision by utilizing real-time data and 3D modeling, allowing for a highly personalized approach tailored to each patient's unique anatomy. By ensuring optimal implant positioning and minimizing surgical errors, the technology significantly improves joint function, reduces recovery time, and enhances overall patient outcomes. With robotic-assisted surgery, we are not only elevating the standard of knee replacement procedures but also providing our patients with a safer, more effective, and long-lasting treatment solution.' With reduced postoperative pain and a faster rehabilitation process, patients can expect shorter hospital stays and quicker recovery times. The minimally invasive nature of robotic-assisted surgery also reduces blood loss and promotes faster healing, contributing to an improved quality of life for individuals undergoing both knee and hip replacement surgeries. This technology is particularly beneficial for patients with severe arthritis or complex anatomical structures, offering them an advanced surgical solution for enhanced mobility and long-term joint health. With this introduction, Aster Hospital Mankhool reaffirms its commitment to integrating innovation and excellence into patient care. This launch represents a transformative step forward in orthopedic treatment, ensuring that patients receive the most precise, effective, and minimally invasive surgical interventions available.
